Does vitamin D deficiency reduce insulin sensitivity and impair insulin secretion?

Vitamin D is a critical regulator of glucose metabolism, with its deficiency strongly linked to metabolic dysfunction. Research indicates that vitamin D status influences both how the body responds to insulin and how the pancreas produces it, particularly in aging and postmenopausal populations.

Clinical and effectiveness evidence

Large-scale observational and longitudinal studies consistently link low serum 25-hydroxyvitamin D [25(OH)D] levels to metabolic impairment.

• Insulin sensitivity: Higher 25(OH)D levels are positively correlated with the insulin sensitivity index (ISI). In postmenopausal women with type 2 diabetes, deficiency is associated with significantly higher HOMA-IR (a measure of insulin resistance), fasting insulin, and HbA1c levels.
• Glucose tolerance: Lower vitamin D levels are predictive of higher 2-hour post-challenge glucose levels during oral glucose tolerance tests (OGTT).
• Disease risk: Data from the UK Biobank (n=379,699) shows that individuals with vitamin D levels ≥75 nmol/L have a 36-38% lower hazard ratio for incident type 2 diabetes. Conversely, deficiency can increase the risk of progressing to prediabetes or diabetes by up to 62% over a four-year period.

Mechanistic explanations

Vitamin D signaling acts through the Vitamin D Receptor (VDR), which is expressed directly in pancreatic beta cells and peripheral tissues.

• Beta cell survival: VDR activation protects beta cells from inflammation and oxidative stress. It counters mitochondrial dysfunction and ROS production, preventing apoptosis (cell death) triggered by inflammatory cytokines like IL-1β.
• Insulin secretion: Active vitamin D (1,25(OH)₂D) directly enhances glucose-stimulated insulin secretion (GSIS). Beta cells treated with vitamin D show significantly higher insulin release during glucose challenges compared to deficient cells.
• Peripheral sensitivity: Vitamin D may improve insulin action by upregulating the expression of insulin receptors and activating PPAR-δ, a regulator of fatty acid metabolism and glucose uptake in muscle and fat tissues.

Bottom line

Vitamin D deficiency is a major risk factor for reduced insulin sensitivity and impaired glucose tolerance. Vitamin D signaling in the pancreas is essential for protecting beta cell mass and ensuring an adequate insulin secretory response to glucose. Keeping vitamin D levels above 75 nmol/L is associated with significantly better metabolic outcomes and a lower risk of type 2 diabetes.